Delivering Reliable & Scalable Radiopharmaceutical Manufacturing by Strengthening Regulatory CMC Understandings, Advancing Production Technologies, Streamlining Logistical Hurdles & Maximizing Isotope Supply
In the high-stakes world of radiopharmaceuticals, the industry is just beginning to realize the full potential of this targeted therapy modality. A surge of capital flowing into the field is signalling not only robust investment, but a shared urgency to strengthen supply pipelines and scale clinical manufacturing capacity.
- Lantheus restructures to sharpen radiopharma focus: acquired CDMO Evergreen Theragnostics for $1B to scale therapeutic manufacturing (January 2025), while divesting its legacy SPECT business to SHINE Technologies to streamline operations in PET diagnostics and next-gen therapeutics (May 2025).
- Philocem AG licenses OncoACP3 to RayzeBio (a Bristol Myers Squibb company) in a deal worth up to $1.35B (June 2025).
- Ratio Therapeutics teams with Wasatch Group to develop 65,000-square-foot radiopharmaceutical research and manufacturing facility, expanding production capacity and infrastructure (May 2025).
Alongside this growth, however, the challenge of consistently delivering safe, scalable, and timely radiopharmaceuticals to patients remains.
The 3rd Targeted Radiopharmaceuticals (TRP) Supply Chain & Manufacturing Summit returned to Boston this September to help strengthen infrastructure, streamline workflows, and future-proof roles in a rapidly evolving and expanding radiopharmaceutical landscape.
We explored how to optimize production capabilities and build a resilient, efficient supply chain by delving into critical topics such as strategic isotope selection, manufacturing scale-up, supplier quality control, regulatory transparency, and last-mile supply networks.
As the only industry-dedicated forum uniting 70+ of the leading C-suite and senior decision-makers in the radiopharmaceutical CMC, regulatory, QC, and supply chain fields, we garnered exclusive technical and logistical insights from the likes of AstraZeneca, Novartis, Clarity Pharmaceuticals, Ratio Therapeutics, ImaginAB, and more.
The conference attracts real subject matter experts and features valuable exchanges of information. I always learn something and make new contacts.
Brookline Capital Markets
It was very well run. Additionally, it was a good collection of individuals focused on a key topic.
Cellectar Biosciences
I like the variety of topics for this industry. This year it was great to hear about safety and automation.
Nucleas Radiopharma
It was a radiopharma meeting that focused on supply chain. Few conferences like this in our industry.
POINT Biopharma
What You Missed Out On:
1
Mitigate drug loss and delivery delays by refining end-to-end supply chain strategies and last-mile coordination with clinical sites, ensuring patients receive critical therapies on time.
2
Advance regulatory readiness through enhanced CMC practices and improved quality system alignment with evolving global standards, reducing compliance risks and accelerating approvals.
3
Strengthen clinical continuity by proactively navigating isotope sourcing challenges and building resilient supplier relationships, minimizing disruptions in clinical and commercial production.
4
Stay ahead of industry shifts by benchmarking against innovative technologies, digital tools, and automation driving scalable manufacturing, gaining competitive advantage and operational efficiency.
5
Future-proof development programs by understanding infrastructure demands and operational models needed to support both clinical and commercial-stage radiopharmaceuticals, enabling sustainable growth and market readiness.
Explore the Full 2025 Event Guide
- Get a full overview of the agenda, speakers, and sessions in one place
- Preview featured case studies that we’ll be shining a light on
- Discover exclusive content such as keynote highlights, attendee benefits and more
- Share easily with colleagues and decision-makers to mobilize interest
Official Partners
Attending Companies Included:
Explore the Agenda
Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.